Globofarm

Globofarm is an Austrian pharmaceutical company that specializes in the development, registration, and distribution of generic and niche medicinal products, particularly for the hospital and specialist sectors. Founded in 1999 and headquartered in Vienna, the company offers a diverse portfolio of high-quality medications in therapeutic areas such as oncology, anti-infectives, and intensive care. In 2014, Globofarm was acquired by AOP Health (formerly AOP Orphan), a leading European pioneer in integrated therapies for rare diseases and critical care. Despite the acquisition, Globofarm continues to operate as a specialized provider of essential generic medicines, leveraging its expertise in the European regulatory environment to provide cost-effective therapeutic alternatives. The company's business model emphasizes strategic partnerships and a strong presence in the Austrian healthcare market.